Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Bile acid analogues are activators of pyrin inflammasome.

Alimov I, Menon S, Cochran N, Maher R, Wang Q, Alford J, Concannon JB, Yang Z, Harrington E, Llamas L, Lindeman A, Hoffman G, Schuhmann T, Russ C, Reece-Hoyes J, Canham SM, Cai X.

J Biol Chem. 2019 Mar 8;294(10):3359-3366. doi: 10.1074/jbc.RA118.005103. Epub 2019 Jan 15.

2.

Discovery of a ZIP7 inhibitor from a Notch pathway screen.

Nolin E, Gans S, Llamas L, Bandyopadhyay S, Brittain SM, Bernasconi-Elias P, Carter KP, Loureiro JJ, Thomas JR, Schirle M, Yang Y, Guo N, Roma G, Schuierer S, Beibel M, Lindeman A, Sigoillot F, Chen A, Xie KX, Ho S, Reece-Hoyes J, Weihofen WA, Tyskiewicz K, Hoepfner D, McDonald RI, Guthrie N, Dogra A, Guo H, Shao J, Ding J, Canham SM, Boynton G, George EL, Kang ZB, Antczak C, Porter JA, Wallace O, Tallarico JA, Palmer AE, Jenkins JL, Jain RK, Bushell SM, Fryer CJ.

Nat Chem Biol. 2019 Feb;15(2):179-188. doi: 10.1038/s41589-018-0200-7. Epub 2019 Jan 14.

PMID:
30643281
3.

Global health policy and neglected tropical diseases: Then, now, and in the years to come.

Fürst T, Salari P, Llamas LM, Steinmann P, Fitzpatrick C, Tediosi F.

PLoS Negl Trop Dis. 2017 Sep 14;11(9):e0005759. doi: 10.1371/journal.pntd.0005759. eCollection 2017 Sep. No abstract available.

4.

Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.

N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.

5.

A Photoaffinity Labeling-Based Chemoproteomics Strategy for Unbiased Target Deconvolution of Small Molecule Drug Candidates.

Thomas JR, Brittain SM, Lipps J, Llamas L, Jain RK, Schirle M.

Methods Mol Biol. 2017;1647:1-18. doi: 10.1007/978-1-4939-7201-2_1.

PMID:
28808992
6.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.

N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.

7.

Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.

Peukert S, Hughes R, Nunez J, He G, Yan Z, Jain R, Llamas L, Luchansky S, Carlson A, Liang G, Kunjathoor V, Pietropaolo M, Shapiro J, Castellana A, Wu X, Bose A.

ACS Med Chem Lett. 2014 Aug 4;5(10):1114-8. doi: 10.1021/ml500240d. eCollection 2014 Oct 9.

8.

Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39.

Bassilana F, Carlson A, DaSilva JA, Grosshans B, Vidal S, Beck V, Wilmeringwetter B, Llamas LA, Showalter TB, Rigollier P, Bourret A, Ramamurthy A, Wu X, Harbinski F, Plonsky S, Lee L, Ruffner H, Grandi P, Schirle M, Jenkins J, Sailer AW, Bouwmeester T, Porter JA, Myer V, Finan PM, Tallarico JA, Kelleher JF 3rd, Seuwen K, Jain RK, Luchansky SJ.

Nat Chem Biol. 2014 May;10(5):343-9. doi: 10.1038/nchembio.1481. Epub 2014 Mar 16.

PMID:
24633354
9.

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis.

Devonshire V, Lapierre Y, Macdonell R, Ramo-Tello C, Patti F, Fontoura P, Suchet L, Hyde R, Balla I, Frohman EM, Kieseier BC; GAP Study Group.

Eur J Neurol. 2011 Jan;18(1):69-77. doi: 10.1111/j.1468-1331.2010.03110.x.

PMID:
20561039
10.

1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.

Miller-Moslin K, Peukert S, Jain RK, McEwan MA, Karki R, Llamas L, Yusuff N, He F, Li Y, Sun Y, Dai M, Perez L, Michael W, Sheng T, Lei H, Zhang R, Williams J, Bourret A, Ramamurthy A, Yuan J, Guo R, Matsumoto M, Vattay A, Maniara W, Amaral A, Dorsch M, Kelleher JF 3rd.

J Med Chem. 2009 Jul 9;52(13):3954-68. doi: 10.1021/jm900309j.

PMID:
19469545
11.

The design and synthesis of a tricyclic single-nitrogen scaffold that serves as a 5-HT2C receptor agonist.

Huck BR, Llamas L, Robarge MJ, Dent TC, Song J, Hodnick WF, Crumrine C, Stricker-Krongrad A, Harrington J, Brunden KR, Bennani YL.

Bioorg Med Chem Lett. 2006 Aug 1;16(15):4130-4. Epub 2006 Jun 5.

PMID:
16750364
12.

The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists.

Huck BR, Llamas L, Robarge MJ, Dent TC, Song J, Hodnick WF, Crumrine C, Stricker-Krongrad A, Harrington J, Brunden KR, Bennani YL.

Bioorg Med Chem Lett. 2006 Jun 1;16(11):2891-4. Epub 2006 Mar 20.

PMID:
16546379
13.

Long-term outcomes after breast conservation therapy for early stage breast cancer in a community setting.

McCloskey SA, Botnick LE, Rose CM, Malcolm AW, Ozohan ML, Mena R, Llamas L, Tao ML.

Breast J. 2006 Mar-Apr;12(2):138-44.

PMID:
16509838
14.

Acute interhemispheric subdural hematoma: two case reports and analysis of the literature.

Llamas L, Ramos-Zúñiga R, Sandoval L.

Minim Invasive Neurosurg. 2002 Mar;45(1):55-8. Review.

PMID:
11932828
15.

Crystal structure of the ectodomain of Methuselah, a Drosophila G protein-coupled receptor associated with extended lifespan.

West AP Jr, Llamas LL, Snow PM, Benzer S, Bjorkman PJ.

Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3744-9. Epub 2001 Mar 13.

16.

Intraluminal crystalloids in struma ovarii. Immunohistochemical, DNA flow cytometric, and ultrastructural study.

Ro JY, Sahin AA, el-Naggar AK, Ordonez NG, Mackay B, Llamas LL, Ayala AG.

Arch Pathol Lab Med. 1991 Feb;115(2):145-9.

PMID:
1992980
17.

Expression of sialylated Leu-M1 antigen in histiocytosis X.

Santamaria M, Llamas L, Ree HJ, Sheibani K, Ho YS, Su IJ, Hsu SM.

Am J Clin Pathol. 1988 Feb;89(2):211-6.

PMID:
3257635
18.

Bone involvement in hairy cell leukemia.

Quesada JR, Keating MJ, Libshitz HI, Llamas L.

Am J Med. 1983 Feb;74(2):228-31.

PMID:
6824003
19.

Needle biopsy diagnosis of thymoma. A case report.

Sajjad SM, Lukeman JM, Llamas L, Fernandez T.

Acta Cytol. 1982 Jul-Aug;26(4):503-6. No abstract available.

PMID:
6957106
20.

Fibrous pseudotumor of testicular tunic.

Sajjad SM, Azizi MR, Llamas L.

Urology. 1982 Jan;19(1):86-8. No abstract available.

PMID:
7058596

Supplemental Content

Loading ...
Support Center